Glucosamine Plus MSM Tablets
Natural health product licensed in Canada
- Licence holder
- NuGale Pharmaceutical Inc.
- NPN or DIN-HM
- 80001918
- Status
- Active licence
- Licence date
- 17 July 2006
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Helps to relieve pain due to osteoarthritis. Factor in the building of healthy cartilage. Protects against the deteriotarion of cartilage from chronic joint diseases. Effective in reducing joint pain.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have hypertension, astham or if symptoms worsen. Consult a health care practitioner if you are taking warfarin. Discontinue using if you have nausea, headache, heartburn, diarrhea, drowsiness, skin reaction or constipation.
- Contre-indications
Do not use if you are have shellfish allergies. Do not use if you are pregnant or breast-feeding. Do not use if oyu ar taking acetaminophen.
- Effets indésirables connus
Can cause mild gastrointestinal problems including nausea, heartburn diarrhea and constipation. Drowsiness, skin reactions, and headaches have been reported. There is concern that glucsamine products might cause allergic reaction in people who are sensitive to shellfish. There is no documentation reports of allergic reactoin to glucosamine in shellfish allergic patients.
Source
Official Health Canada record, licence 80001918
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.